Results 101 to 110 of about 8,618 (210)

Association between soluble suppression of tumorigenicity 2 and risk and severity of coronary artery disease: a case control study

BMC Cardiovascular Disorders
Background To investigate the differential expression of soluble suppression of tumorigenicity 2 (sST2) in patients with coronary artery disease (CAD) and healthy controls, and the correlation between sST2 and the severity of coronary artery ...
Shuai Zhang, Lu Qian, Shibao Li, Zhijian Liu   +3 more
doaj   +1 more source

Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates.

PLoS ONE, 2017
BackgroundSolubility of Tumorigenicity 2 (sST2) is a novel biomarker that better stratifies risk of cardiovascular events (CVE) compared to cardiac troponin T(cTnT) in heart failure.
Mira T Keddis, Ziad El-Zoghby, Bruce Kaplan, Jeffrey W Meeusen, Leslie J Donato, Fernando G Cosio, D Eric Steidley   +6 more
doaj   +1 more source

The diagnostic and prognostic value of soluble ST2 in Sepsis

Frontiers in Medicine
ObjectiveTo determine the diagnostic and prognostic value of soluble suppression of tumorigenicity 2 (sST2) in patients with sepsis.MethodsA total of 113 critically ill patients were enrolled at the emergency department of Beijing Chaoyang Hospital Jing ...
Xinghua Ye, Jia Wang, Le Hu, Ying Zhang, Yixuan Li, Jingchao Xuan, Silu Han, Yifan Qu, Long Yang, Jun Yang, Junyu Wang, Bing Wei   +11 more
doaj   +1 more source

Assessment of combined serum sST2 and AFP levels in the diagnosis of hepatocellular carcinoma [PDF]

PeerJ
Background Hepatocellular carcinoma (HCC) is a common malignant tumor with high morbidity and mortality. Alpha-fetoprotein (AFP) is the most widely used diagnostic serum biomarker, but it still has limited accuracy in detecting HCC, suggesting the ...
Xiuxin Tang, Dong Wang, Tangdan Ding, Rongqi Lin, Meifang He, Ruizhi Wang, Liubing Li   +6 more
doaj   +2 more sources

sST2, producción y papel en las enfermedades cardiacas

, 2022
INTRODUCCIÓN Las concentraciones séricas del ST2, un miembro de la familia de receptores interleucina-1 (IL-1), son un importante marcador pronóstico en enfermedades cardíacas. sST2 está elevado en la sangre periférica de pacientes con infarto agudo de miocardio (IAM) e insuficiencia cardiaca (IC).
openaire   +1 more source

Serum Soluble ST2 and Adverse Left Ventricular Remodeling in Patients With ST-Segment Elevation Myocardial Infarction

Clinical Medicine Insights: Cardiology, 2019
Objective: To assess the dynamics of serum levels of soluble isoform of suppression of tumorigenicity 2 (sST2) and N-terminal pro-brain natriuretic peptide (NT-proBNP) and their correlations with the development of adverse left ventricular remodeling ...
Maria Kercheva, Tamara Ryabova, Anna Gusakova, Tatiana E Suslova, Vyacheslav Ryabov, Rostislav S Karpov   +5 more
doaj   +1 more source

Associations of Soluble Serum Stimulation‐2 With Functional Outcomes and Death at 1 Year in Acute Ischemic Stroke: A Prospective Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Elevated sST2 (soluble serum stimulation‐2) has been associated with poor 90‐day outcomes of patients with acute ischemic stroke (AIS). We aimed to investigate the associations between baseline serum sST2 level and 1‐year outcomes in patients ...
Xuan Tian, Xiao Wang, Lulu Pei, Kai Liu, Yuan Gao, Yuming Xu, Xinyi Leng, Bo Song   +7 more
doaj   +1 more source

Diagnostic value of serum soluble suppression of tumorigenicity 2 in patients with heart failure in different types of heart diseases

Zhongguo linchuang yanjiu
Objective To observe the changes of soluble growth stimulation expression gene 2 (sST2) level in patients with heart failure in different types of heart diseases, and analyze the diagnostic value of sST2 in heart failure. Methods A total of 74 patients
XIA Li*, YIN Yi, ZHOU Dewei, WU Jiaming, WANG Hongzhi
doaj   +1 more source

Soluble suppression of tumorigenicity 2 associated with left ventricular thrombosis in patients with ST-segment elevation myocardial infarction

BMC Cardiovascular Disorders
Background Left ventricular thrombosis (LVT) after acute ST-segment elevation myocardial infarction (STEMI) is closely related to inflammation. Soluble Suppression of Tumorigenicity 2 (sST2) expressed as a novel inflammatory marker, has received much ...
Xinjia Du, Perkash Kumar, Chen Liu, Jiahua Liu, Lei Chen, Yuan Lu, Zhuoqi Zhang   +6 more
doaj   +1 more source

Association between sST2 Levels and Cardiovascular Outcomes and Effect of Sacubitril/Valsartan on sST2 Levels: Results From the PARADIGM-HF Trial [PDF]

Journal of Cardiac Failure, 2016
Eileen O'Meara, Margaret F. Prescott, Jean L. Rouleau, Lu-May Chiang, Scott D. Solomon, Karl Swedberg, Milton Packer, John J.V. McMurray, Michael R. Zile   +8 more
openaire   +1 more source